Affimed announces strategic restructuring, reducing headcount by 50%

Affimed “announces a restructuring initiative aimed at transforming the Company into a focused clinical organization, positioned to successfully advance its clinical programs to key value inflection points. Key highlights of the restructuring plan include: Focus on Clinical Programs: Affimed will direct all resources towards advancing the development of its clinical programs; Workforce reduction – Affimed will reduce its workforce by up to 50% by dissolving its research and preclinical development departments, aligned with the Company’s narrowed strategic priorities; Prolonged Cash Runway – The restructuring plan announced today will extend Affimed’s cash runway into H2 of 2025.”